AGP Executive Report
Last update: 7 hours agoMedical Cannabis Expansion (Georgia): Georgia’s medical cannabis program just expanded under a new law, lifting the old 5% THC cap and adding new qualifying conditions plus new product options like flower and vaping—patients say faster relief matters most. Product Safety (Arizona): Arizona recalled a marijuana product after inspectors found a lab misreported failed Aspergillus testing as passing; officials say no illnesses reported yet and urge at-risk buyers to toss it. CBD Research (Anxiety/Depression): A new preclinical review in Molecular Psychiatry suggests CBD could help anxiety- and depression-like behaviors and cognition in animal studies, but human benefits still aren’t proven. Sleep & Dosing (Melatonin): A sleep-aid spotlight warns that melatonin can be helpful but product inconsistencies and improper dosing can cause real harms. Policy Watch (Tennessee): Tennessee’s THCA ban took effect July 1, tightening what hemp retailers can sell, while lawmakers and businesses brace for fallout. Addiction & Recovery (Kratom/Kava): North Carolina coverage highlights the ongoing debate over kratom and 7-OH access, with doctors and policymakers arguing over addiction risk vs. availability. Public Health (Heat): Health officials issued heat-safety reminders to prevent heat cramps, exhaustion, and stroke. Local Life (Pets & Fireworks): Animal groups urge pet owners to keep alcohol, cannabis products, and other toxins away during Fourth of July celebrations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
